Skip to main content

TMEM147 KO cell lysate available now. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 2.

Be the first to review this product! Submit a review

Images

Sanger Sequencing - Human TMEM147 knockout HEK-293T cell lysate (AB259186), expandable thumbnail

Key facts

Cell type
HEK-293T
Species or organism
Human
Tissue
Kidney
Knockout validation
Sanger Sequencing
Mutation description
Knockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 2.

Alternative names

What's included?

1 Kit
Components
Human TMEM147 knockout HEK293T cell lysate
1 x 100 µg
Human wild-type HEK293T cell lysate
1 x 100 µg

Recommended products

TMEM147 KO cell lysate available now. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 2.

Key facts

Cell type
HEK-293T
Mutation description
Knockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 2.
Concentration
Loading...

Properties

Gene name
TMEM147
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous

Quality control

STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level
EU: 2 US: 2
Adherent/suspension
Adherent
Gender
Female

Storage

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Notes


Knockout cell lysate achieved by CRISPR/Cas9.

Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.
Activity summary

TMEM147 also known as NBR1 is a transmembrane protein with a molecular mass of approximately 28 kDa. It resides primarily in the endoplasmic reticulum and is widely expressed across various tissues such as the brain and liver. The protein spans the membrane multiple times indicating its role in maintaining cellular structure and function within the membrane environment. TMEM147 is often associated with regulatory processes that affect membrane-related activities.

Biological function summary

TMEM147 interacts with proteins in the ribosome maturation process and is involved in assembling the nuclear pore complex. It forms part of the N-oligosaccharyltransferase (OST) complex which plays an essential role in protein modification through glycosylation. This complex activity helps in the proper folding and stability of proteins necessary for cell function. Therefore TMEM147 influences cellular processes by regulating the maturation and transport of proteins within cells.

Pathways

TMEM147 contributes significantly to the N-glycosylation and protein biosynthesis pathways. Within these pathways the protein interacts with enzymes like STT3A and STT3B which are key catalytic components of the oligosaccharyltransferase complex. Through this interaction TMEM147 ensures proper protein folding and efficiency in glycoprotein processing. It also influences cellular homeostasis and stress responses by coordinating with proteins related to ER stress pathways.

Associated diseases and disorders

TMEM147 shows a connection to neurodegenerative diseases and certain types of cancer. Studies highlight its involvement in Alzheimer's disease where it interacts with the γ-secretase complex including proteins like presenilin-1 (PSEN1) affecting amyloid-beta precursor protein processing. In cancer abnormal TMEM147 expression correlates with altered N-glycosylation patterns leading to changes in tumor cell behavior. This association suggests TMEM147's potential role as a biomarker or therapeutic target in disease management.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

1 product image

  • Sanger Sequencing - Human TMEM147 knockout HEK-293T cell lysate (ab259186), expandable thumbnail

    Sanger Sequencing - Human TMEM147 knockout HEK-293T cell lysate (ab259186)

    Homozygous: Insertion of the selection cassette in exon 2

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com